Accenture Acquires Alfahealth, Expanding Digital Health Capabilities for Italy's Healthcare Transformation

Accenture has agreed to buy Alfahealth, a digital health company owned by Italy's Engineering Group, the consulting giant announced on June 17, 2026 AP News. The deal brings roughly 1,200 specialists — including clinicians, designers, and tech consultants — into Accenture's health practice, along with more than two decades of experience building clinical and administrative software for the Italian market.
Financial terms were not disclosed. The transaction is subject to standard closing conditions Business Wire.
Alfahealth runs a service-led digital health platform built specifically for Italy. Its core product, called ellipse, is an electronic medical record (EMR) system. It helps hospitals modernize clinical workflows — the step-by-step processes doctors and nurses use to treat patients — and connect patient data across different care settings Business Wire. The platform also handles administrative tasks like scheduling and billing.
Accenture Italy CEO Teodoro Lio said the company brings "deep healthcare expertise, trusted relationships... and capabilities for digitizing and orchestrating clinical and administrative processes." His goal: "help healthcare providers enable more connected, data-driven experiences for all Italians" AP News.
The deal is directly tied to Italy's national recovery plan, known as the PNRR. Mission 6 of that plan earmarks €8.63 billion specifically for healthcare digitization Street Insider. The funding requires Italy to open 1,350 Community Health Houses and 400 Community Hospitals by 2026. Each of those facilities needs exactly the kind of "services-plus-platform" model that Alfahealth provides.
Italy is also rolling out FSE 2.0 — a national electronic health record system that lets a patient's medical data follow them across regions. Italy's fragmented regional health system has long made this difficult. The Italian digital health market is projected to reach €4.2 billion by 2027, growing at 12.3% per year, according to research from Politecnico di Milano Business Wire.
For Engineering Group, the sale is a strategic exit. New CEO Aldo Bisio took over in April 2025 and launched a review of the group's roughly €1.8 billion revenue portfolio Street Insider. Analysts see the Alfahealth sale not as a sign of weakness but as a deliberate move to shed a specialized medical unit and concentrate on Engineering Group's core identity as a broader digital services champion.
Accenture, meanwhile, has been on a buying spree in Italy. The company previously acquired Intellera Consulting (1,400 staff) and SirfinPA to grow its public sector work, and bought Cabel Industry in December 2025 AP News. Alfahealth is its clearest move yet into Italian healthcare.
The deal raises a tension worth noting. Accenture EMEA CEO Mauro Macchi has publicly championed "Sovereign AI" — the idea that European organizations must keep sensitive data, especially in healthcare, under local control and away from foreign reliance Business Wire. Yet Accenture itself is a Dublin-headquartered global firm. It will now manage health records for millions of Italian citizens.
Italian labor unions and regional IT managers have also raised concerns. Getting healthcare workers to adopt new digital tools requires a huge organizational effort that, in their view, stretches "far beyond the PNRR timeframe." Accenture reported $70 billion in revenue for FY2025 and carried a market cap of roughly $101.6 billion at the time of the announcement Street Insider.
Publishers
10
Articles
10
Reach
10